Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 363 followers
Latest posts
Last updated about 4 hours ago
Amid FDA tumult, agency misses decision deadline on Novavax's COVID shot
about 4 hours ago
Amid a period of great upheaval at the agency, the FDA has...
After patient death, Sarepta and Roche pause 3 trials of gene therapy Elevidys in Europe
about 8 hours ago
In response to a request from the European Medicines Agency following the...
Novo's commercial strategy head hits the exit, prompting a slew of executive team shakeups
about 8 hours ago
Camilla Sylvest is stepping down from her role as executive vice president...
Vanrafia, 2nd drug in Novartis' IgAN troika, crosses FDA finish line in payday for Chinook investors
about 8 hours ago
The FDA's approval for Novartis' atrasentan in the kidney disease IgAN means...
Nxera Pharma appoints AstraZeneca alum as inaugural commercial chief
about 8 hours ago
As Nxera Pharma proceeds into the “next era” implied by its name—following...
FDA inspection operations face risk of further disruption amid mass HHS layoffs: report
about 9 hours ago
While the FDA’s inspection figures for drug manufacturing facilities have yet to...
Havas Health adds execs at nascent New York agency as Real Chemistry strengthens in Europe
about 10 hours ago
Agencies made moves on both sides of the Atlantic Wednesday, with Havas...
As Trump's 'Liberation Day' tariffs seem to spare pharmaceuticals, threat of industry-specific duties and loopholes persists
about 24 hours ago
On Wednesday, President Donald Trump unveiled another wave of tariffs but did...
With biosimilar competition looming, Roche takes a hit with failure of high-dose Ocrevus
1 day ago
With its multiple sclerosis powerhouse Ocrevus expected to lose patent protection by...
For struggling cell and gene therapy field, Peter Marks' FDA exit adds even more uncertainty
1 day ago
To innovators in the cell and gene therapy field, Peter Marks’ exit...
Japan's Marubeni takes on Sumitomo's Asia pharma business to make new company in deal worth up to $480M
1 day ago
Japanese conglomerate Marubeni is getting a 60% stake in the new company...
FDA taps insider Scott Steele to lead CBER on acting basis after Peter Marks departure
1 day ago
Amid a dramatic reshaping of the federal healthcare apparatus, the FDA has...